Insider buying
~$250K22K sh @ $11.22
Traded Nov 29, 2023 · filed 491 days later
The CFO of Agilon Health paid $250K out of pocket for Agilon Health shares.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
AGL · NYSE · Services-Misc Health & Allied Services, Nec
Agilon Health (AGL) · oqro.io/stocks/AGL · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$90.24+0.74 (+0.83%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Insider buying
Traded Nov 29, 2023 · filed 491 days later
The CFO of Agilon Health paid $250K out of pocket for Agilon Health shares.
Insider buying
Traded Dec 13, 2024 · filed the same day
Since the trade +61.1% · S&P 500 +14.2% · to Nov 20
An Agilon Health director paid $55K out of pocket for Agilon Health shares. 3 other people at Agilon Health bought some too, in the same month. It was the first purchase in over a year.
Insider buying
Traded Dec 11, 2024 · filed 2 days later
Since the trade +81.4% · S&P 500 +13.6% · to Nov 20
An Agilon Health director paid $50K out of pocket for Agilon Health shares. 3 other people at Agilon Health bought some too, in the same month. It was the first purchase in over a year.
Insider buying
Traded Dec 5, 2024 · filed 6 days later
Since the trade +63.3% · S&P 500 +13.7% · to Nov 20
An Agilon Health director paid $98K out of pocket for Agilon Health shares. 3 other people at Agilon Health bought some too, in the same month. It was the first purchase in over a year.
Traded Nov 25 – Dec 9, 2024 · largest single transaction ~$28K
Nov 25, 2024~$28K · 13K sh @ $2.28
DetailsOfficial recordDec 9, 2024~$16K · 7,500 sh @ $2.20
DetailsOfficial record0 open-market purchases and 0 open-market sales by insiders of AGL between Jan 26, 2026 and today, placed against the company's last 4 earnings releases. The latest on file was filed Nov 4, 2026. The data provider lists the next release for Feb 23, 2027; that date may change.
PurchaseSale30 days before a release30 days after
| Earnings release | 30 days before | On the day | 30 days after |
|---|---|---|---|
| Nov 4, 2026 | None | None | None |
| Aug 5, 2026 | None | None | None |
| May 6, 2026 | None | None | None |
| Feb 25, 2026 | None | None | None |
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies